Cordani David's Form 4 filing
Cigna Group (CI) · filed Mar 25, 2024
- Accession no.
- 0001225208-24-004481
- Filed
- Mar 25, 2024
- Trade date
- Mar 21-25, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $14.1M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cordani DavidCIK 0001318751 | Director, Officer (Chairman & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 21, 2024 | Common Stock, $.01 Par Value | MOption exerciseAcquired | +2,293 | $139.22 | +$319,231.46 | 350,347 | Direct | |
| Mar 21, 2024 | Common Stock, $.01 Par Value | SSaleDisposed | −2,293 | $355.02F2 | −$814,060.86 | 348,054 | Direct | |
| Mar 22, 2024 | Common Stock, $.01 Par Value | MOption exerciseAcquired | +6,338 | $139.22 | +$882,376.36 | 354,392 | Direct | |
| Mar 22, 2024 | Common Stock, $.01 Par Value | SSaleDisposed | −6,338 | $355.11F3 | −$2,250,687.18 | 348,054 | Direct | |
| Mar 25, 2024 | Common Stock, $.01 Par Value | MOption exerciseAcquired | +31,209 | $139.22 | +$4,344,916.98 | 379,263 | Direct | |
| Mar 25, 2024 | Common Stock, $.01 Par Value | SSaleDisposed | −31,209 | $355.17F4 | −$11,084,500.53 | 348,054 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 21, 2024 | Common Stock, $.01 Par Value | MOption exerciseDisposed | −2,293 | $0.00 | $0 | 45,308 | Direct | |
| Mar 22, 2024 | Common Stock, $.01 Par Value | MOption exerciseDisposed | −6,338 | $0.00 | $0 | 38,970 | Direct | |
| Mar 25, 2024 | Common Stock, $.01 Par Value | MOption exerciseDisposed | −31,209 | $0.00 | $0 | 7,761 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average price of the shares sold. The prices actually received ranged from $355.00 to $355.13 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average price of the shares sold. The prices actually received ranged from $355.00 to $355.46 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average price of the shares sold. The prices actually received ranged from $355.00 to $355.70 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
Referenced by the price of 1 transaction in Table I.